63783-52-8

(9alpha,13alpha,14alpha)-17-[2-(4-aminophenyl)ethyl]morphinan-3-ol

2H-Pyran-2-one, 5,6-dihydro-5-hydroxy-5,6-bis(3-methoxyphenyl)-,(5S,6R)-

Methanone, phenyl(tetrahydro-3-furanyl)-, oxime, (E)-

2-Butenoic acid, 4-(3,4-dimethyl-5-oxo-2(5H)-furanylidene)-3-methyl-,ethyl ester, (Z,E)-

1H-Benzimidazole, 2-[2-[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]phenyl]-

1H-Inden-2-ol, 2-(aminomethyl)-2,3-dihydro-1-(2-methylphenoxy)-,(1R,2S)-

Morpholine, 4-(3-phenylpropyl)-

2-Butenoic acid, 4-(4-ethylphenyl)-4-oxo-

2H-Pyran-2-one, 6-cyclohexyltetrahydro-, (6S)-

Mercury, chloro(3,3,3-trinitropropyl)-

2-Cyclohexen-1-one, 3-[(3-aminophenyl)amino]-5,5-dimethyl-

2H-Pyran-2-one, 6-(chloromethyl)-5,6-dihydro-, (6R)-

2H-Pyran-2-one, 5-[3-(cyclopentyloxy)-4-methoxyphenyl]tetrahydro-,(5S)-

2H-Pyran-2-one, 5,6-dihydro-6-methyl-6-(2-phenylethyl)-, (6S)-

4-Quinolinecarbonyl chloride, 2-(2-thienyl)-

2-Cyclohexen-1-one, 3-(4-methoxyphenyl)-6-(4-pentylphenyl)-

2-Cyclohexen-1-one, 3-(hexylamino)-2-methoxy-

1H-Imidazo[4,5-g]quinoxaline-6,7-dione,5,8-diethyl-5,8-dihydro-2-(4-methylphenyl)-

2-Cyclohexen-1-one, 3-[(2-iodophenyl)amino]-

2H-Pyran-2-one, 5,6-dihydro-4-iodo-3-methyl-

2-Propanol, 1-iodo-3-(phenylmethoxy)-

2-Butenoic acid, 4-(3,4-dimethyl-5-oxo-2(5H)-furanylidene)-3-methyl-,ethyl ester, (E,E)-

2-Butenoic acid, 4-(4-fluorophenyl)-2-hydroxy-4-oxo-, (2Z)-

2-Butenoic acid, 3-methyl-4-(triphenylphosphoranylidene)-, methylester, (2E)-

2-[[4-[3-(6-methyl-4-oxo-2-sulfanylidene-1h-pyrimidin-5-yl)propanoylamino]benzoyl]amino]pentanedioic Acid

1H-Pyrrolizine-1,3(2H)-dione,tetrahydro-2-(1-hydroxy-2-heptadecenylidene)-

2H-Pyran-2-one, 5-[3-(acetyloxy)-4-methoxyphenyl]tetrahydro-, (5S)-

2H-Pyran-2-one, 5,6-dihydro-6-(2-phenylethyl)-, (6R)-

Acetic acid, [[(diethylamino)carbonyl]oxy]-, methyl ester

2-Propenoic acid, 3-[2'-(2H-azirin-3-yl)[1,1'-biphenyl]-2-yl]-, methylester, (E)-

Butanedioic acid, sulfo-, 4-(2-ethylhexyl)1-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl) ester, sodium salt

2-Cyclohexen-1-one, 3-[(2-nitrophenyl)methoxy]-

2-Benzoxazolamine,6-[2-[5-[(dimethylamino)methyl]-2-furanyl]ethyl]-N-ethyl-, 2-butenedioate(2:3)

L-Aspartic acid, N-[bis(1-methylethoxy)phosphinyl]-, 1-(phenylmethyl)ester

2H-Pyran-2-one, 5,6-dihydro-4-(4-methoxybenzoyl)-

1H-Imidazo[4,5-g]quinoxaline-6,7-dione,5,8-diethyl-5,8-dihydro-2-phenyl-

2-Butenoic acid, 3-methyl-4-[(2-nitrophenyl)amino]-, ethyl ester

63783-52-8 msds

CAS No 63783-52-8 supplier

CASNo 63783-52-8 distributor

CAS # 63783-52-8 manufacturer

CAS Number 63783-52-8 safety

CAS RN 63783-52-8 wholesale

2026-10-14 Find (9alpha,13alpha,14alpha)-17-[2-(4-aminophenyl)ethyl]morphinan-3-ol,CAS No.63783-52-8,Formula:C24H30N2O in 9CMX